At hVIVO, we are at the forefront of infectious disease research, playing a pivotal role in the development of vaccines and therapeutics across a broad range of indications. Renowned for our expertise in human challenge models, hVIVO’s Human Challenge Models accelerate and inform clinical development by enabling the controlled testing of vaccines and treatments for infectious and respiratory diseases.
To date, we have successfully developed human challenge models for major respiratory pathogens, including influenza, RSV, hMPV, HRV, and COVID-19. Our capabilities, however, extend beyond respiratory illnesses and Human Challenge Models. With a deep bench of scientific and medical expertise, we are expanding into other areas, including bacterial infections and emerging diseases such as Dengue—now increasingly prevalent beyond traditional tropical regions.
Our recent move to a state-of-the-art facility in Canary Wharf, London, coupled with our expansion to our screening and outpatient clinical trial unit, significantly enhances our capacity. We are now equipped with a trial unit with Containment Level 3 (BSL-3) pathogen control measures with onsite BSL-3 laboratories. This advanced infrastructure enables us to support a wider range of pathogens —including norovirus, dengue virus, Zika virus, and bacteria such as Bordetella pertussis—across both early-phase human challenge studies and large-scale Phase II and Phase III clinical trials.
At hVIVO, we bring decades of proven expertise in virology and vaccine development, with a clear mission: to reduce the global burden of preventable infectious diseases. Within the hVIVO Group, our dedicated teams specialise in the strategic planning and seamless execution of clinical vaccination trials.
Our approach is rooted in scientific rigour and operational excellence. From intelligent trial design and proactive participant recruitment to robust safety oversight and comprehensive data analysis, we deliver high-quality, end-to-end clinical trial solutions. By adhering strictly to FDA and EMA regulatory guidelines, we ensure our studies meet the highest standards of quality, safety, and compliance.
Partner with hVIVO to accelerate your vaccine development programs with confidence, efficiency, and scientific integrity.
Building on decades of experience, our expert scientists, and clinicians have accumulated a wealth of knowledge on infectious diseases; they are often requested to provide their opinion by leading papers and media outlets. Leveraging this knowledge, and with our team of accomplished professionals and modern facilities, we uphold the highest standards of clinical research. Our services include
Expert input on trial design (consultancy)
Trial management & data management
Quick and effective recruitment
Specialist virology, immunology, and molecular laboratory services
Biometrics
Reporting
Sign up to our emails and follow us on social media to keep up to date with hVIVO.
